Gregory L. Shiferman is of Sage Therapeutics, Inc.. Currently has a direct ownership of 30,759 shares of SAGE, which is worth approximately $225,155. The most recent transaction as insider was on Feb 24, 2025, when has been sold 2,502 shares (Common Stock) at a price of $7.49 per share, resulting in proceeds of $18,739. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K
54.05% 3M change
n/a 12M change
Total Value Held $225,155

Gregory L. Shiferman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
SELL
Payment of exercise price or tax liability
$18,739 $7.49 p/Share
2,502 Reduced 7.52%
30,759 Common Stock
Feb 13 2025
SELL
Payment of exercise price or tax liability
$4,501 $7.18 p/Share
627 Reduced 1.85%
33,261 Common Stock
Jan 16 2025
BUY
Grant, award, or other acquisition
-
14,000 Added 29.23%
33,888 Common Stock
Dec 24 2024
SELL
Payment of exercise price or tax liability
$432 $5.48 p/Share
79 Reduced 0.4%
19,888 Common Stock
Nov 01 2024
BUY
Grant, award, or other acquisition
-
5,000 Added 20.03%
19,967 Common Stock
GLS

Gregory L. Shiferman

Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Track Activities on SAGE